Remedium Lifecare (RLC) Announces 3:1 Bonus Shares: Key Record Date and Details Inside

<ul>
    <li>The Board of Directors of Remedium Lifecare Limited has declared the issuance of bonus shares to its eligible shareholders.</li>
    <li>This decision was made during the board meeting on Monday, which also discussed the company's unaudited financial results for Q4FY24.</li>
    <li>The bonus shares will be issued in a 3:1 ratio, marking the second issuance within a year.</li>
</ul>
<p><strong>Remedium Lifecare Limited announces a 3:1 bonus share issuance, reflecting its commitment to shareholder value and growth.</strong></p>
<h2><strong>Remedium Lifecare Bonus Shares Details</strong></h2>
<p>Remedium Lifecare informed us about the development regarding bonus shares, saying, "Subject to the approval of the members in the Annual General Meeting and appropriate authorities, the Board has considered, approved, and recommended a Bonus Issue of 3 Equity Shares of Re. 1/- each fully paid up for every 1 Equity Share of Re. 1/- Each fully paid-up is held as of the Record date decided for this purpose. The Bonus Shares, once allotted, shall rank pari-passu in all respects and carry the same rights as the existing Equity Shares and shall be entitled to participate in full in any dividend and other corporate action recommended and declared after the issue and allotment of such Bonus Shares."</p>
<h3><strong>Remedium Lifecare Bonus Shares Record Date</strong></h3>
<p>"The Record Date for the Bonus Issue of Equity Shares in a ratio of 3:1, i.e., Three Equity Shares of Re. 1/- each fully paid up for every One Equity Share of Re. 1/- each fully paid upheld as on the record date decided for this purpose (if approved by the shareholders in the Annual General Meeting) is Saturday, 06 July 2024," the company reiterated in its exchange filing. We are committed to maintaining transparency and keeping our shareholders informed about every step of this process.</p>
<h3><strong>Remedium Lifecare Bonus Share History</strong></h3>
<p>As mentioned earlier, the company's AGM approved the bonus share proposal, marking another successful milestone for Remedium Lifecare. This will be the second time in less than a year that our small-cap stock will trade ex-bonus, following the successful ex-bonus trading on 28 July 2023 to finalize the list of eligible shareholders for the issuance of bonus shares in a 9:5 ratio. This success reflects our commitment to our shareholders and our continuous growth and prosperity.</p>
<h3><strong>Conclusion</strong></h3>
<p>The issuance of bonus shares by Remedium Lifecare Limited underscores the company's dedication to enhancing shareholder value and fostering growth. With the record date set for 6 July 2024, shareholders can look forward to this significant development. This move, being the second bonus issuance within a year, highlights the company's robust financial health and its commitment to rewarding its investors. As always, shareholders are encouraged to stay informed and consult with financial advisors to understand the implications of this bonus issue on their investments.</p>